Life Sciences
_0.jpg?m=1782722281 "Ein Gespräch mit Martin King zu den 4 R's von 2026: Reliance, Realignment, Rationalisation, Resilience")
The 4 R's of 2026
What do reliance, realignment, rationalization, and resilience actually mean for regulatory affairs and quality management? Martin King provides some insight.
From Lifecycle Control to System Trust
Interview with Matthias Pohl on data-driven regulation, the FDA's ELSA platform, and what right-first-time really means.
Coopers Life Sciences Circle in April 2026
The Coopers Life Sciences Circle 2026 brought together senior experts in Regulatory Affairs and Pharma Quality for an evening of sharp insights and meaningful exchange.
Coopers Life Sciences Circle 2025
At the first Coopers Life Sciences Circle at the Orangerie Basel, industry experts came together to network.
Coopers at Ironwood Pharmaceuticals
Coopers supports IT roll-out at long-standing client VectivBio following acquisition by Ironwood.
Coopers Life Sciences – Interview with Saad Bendadi, Bussiness Manager Life Sciences
Today we get to share some insights from our Business Manager Life Sciences – Saad Bendadi. Saad has been a part of the ...
Coopers Life Sciences – Recruiting Life Sciences Experts
Life sciences describes a fascinating industry and includes research areas like pharmacy, biology and chemistry as well ...
Strategic Partnership with Bayer Consumer Care AG
Bayer and Coopers signed a strategic partnership entailing the recruitment of external specialists in Switzerland. After ...
_1.svg)